Gary Nachman
Stock Analyst at Canaccord Genuity
(2.06)
# 3,298
Out of 5,119 analysts
504
Total ratings
45.7%
Success rate
0.2%
Average return
Main Sectors:
Stocks Rated by Gary Nachman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ANIP ANI Pharmaceuticals | Reiterated: Hold | $90 | $67.41 | +33.51% | 7 | Nov 6, 2026 | |
| ETON Eton Pharmaceuticals | Reiterated: Buy | $68 → $80 | $56.46 | +41.69% | 4 | Nov 6, 2026 | |
| ADMA ADMA Biologics | Reiterated: Buy | $18 → $19 | $12.73 | +49.25% | 10 | Nov 5, 2026 | |
| AMGN Amgen | Reiterated: Hold | $384 → $440 | $460.42 | -4.44% | 7 | Nov 4, 2026 | |
| JAZZ Jazz Pharmaceuticals | Reiterated: Buy | $300 | $234.76 | +27.79% | 54 | Nov 3, 2026 | |
| ABBV AbbVie | Reiterated: Buy | $290 → $338 | $291.31 | +16.03% | 48 | Nov 2, 2026 | |
| IONS Ionis Pharmaceuticals | Reiterated: Buy | $85 | $39.42 | +115.63% | 40 | Oct 28, 2026 | |
| TNXP Tonix Pharmaceuticals Holding | Reiterated: Buy | $18 | $4.74 | +279.75% | 1 | Oct 28, 2026 | |
| ASND Ascendis Pharma | Initiated Coverage: Hold | $268 | $256.82 | +4.35% | 1 | Oct 26, 2026 | |
| ACHV Achieve Life Sciences | Reiterated: Buy | $13 | $6.72 | +93.45% | 10 | Oct 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $62 | $46.94 | +32.08% | 15 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $36.43 | n/a | 48 | Oct 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16.94 | $9.71 | n/a | 7 | Oct 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3 → $20 | $2.12 | n/a | 2 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $1.13 | n/a | 5 | Aug 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $37 → $40 | $3.50 | n/a | 2 | Jul 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $3.61 | n/a | 18 | Jun 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $19 → $22 | $19.99 | n/a | 2 | Feb 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $298 | $155.94 | n/a | 23 | Jan 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 → $4 | $61.01 | n/a | 7 | Aug 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $200 → $100 | $0.0001 | n/a | 8 | Mar 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 → $4 | - | n/a | 22 | Mar 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $4 | $20.14 | n/a | 19 | Mar 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 → $30 | $5.25 | n/a | 7 | Mar 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $83 → $78 | $29.82 | n/a | 5 | Mar 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $14 | $19.91 | n/a | 17 | Feb 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $11.29 → $14.11 | $11.56 | n/a | 42 | Feb 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $40 → $32 | $11.88 | n/a | 11 | Feb 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $3 | $39.65 | n/a | 11 | Jan 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $60 → $35 | $0.000001 | n/a | 10 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $27 → $25 | $6.14 | n/a | 6 | Aug 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $180 | $0.9498 | n/a | 3 | Aug 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $13 → $12 | $14.33 | n/a | 5 | May 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $21 | $28.49 | n/a | 14 | May 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 → $3 | $0.000001 | n/a | 5 | Sep 5, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $80 | $61.86 | n/a | 1 | Sep 14, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $138 | $105.59 | n/a | 3 | Apr 27, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $9.5 → $14 | $4.39 | n/a | 2 | Mar 21, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $6.8 | $11.61 | n/a | 2 | Oct 9, 2013 |
ANI Pharmaceuticals
Nov 6, 2026
Reiterated: Hold
Price Target: $90
Current: $67.41
Upside: +33.51%
Eton Pharmaceuticals
Nov 6, 2026
Reiterated: Buy
Price Target: $68 → $80
Current: $56.46
Upside: +41.69%
ADMA Biologics
Nov 5, 2026
Reiterated: Buy
Price Target: $18 → $19
Current: $12.73
Upside: +49.25%
Amgen
Nov 4, 2026
Reiterated: Hold
Price Target: $384 → $440
Current: $460.42
Upside: -4.44%
Jazz Pharmaceuticals
Nov 3, 2026
Reiterated: Buy
Price Target: $300
Current: $234.76
Upside: +27.79%
AbbVie
Nov 2, 2026
Reiterated: Buy
Price Target: $290 → $338
Current: $291.31
Upside: +16.03%
Ionis Pharmaceuticals
Oct 28, 2026
Reiterated: Buy
Price Target: $85
Current: $39.42
Upside: +115.63%
Tonix Pharmaceuticals Holding
Oct 28, 2026
Reiterated: Buy
Price Target: $18
Current: $4.74
Upside: +279.75%
Ascendis Pharma
Oct 26, 2026
Initiated Coverage: Hold
Price Target: $268
Current: $256.82
Upside: +4.35%
Achieve Life Sciences
Oct 22, 2026
Reiterated: Buy
Price Target: $13
Current: $6.72
Upside: +93.45%
Aug 12, 2026
Reiterated: Buy
Price Target: $62
Current: $46.94
Upside: +32.08%
Oct 6, 2025
Reiterated: Hold
Price Target: n/a
Current: $36.43
Upside: n/a
Oct 2, 2025
Reiterated: Buy
Price Target: $16.94
Current: $9.71
Upside: n/a
Aug 13, 2025
Reiterated: Buy
Price Target: $3 → $20
Current: $2.12
Upside: n/a
Aug 4, 2025
Reiterated: Hold
Price Target: n/a
Current: $1.13
Upside: n/a
Jul 31, 2025
Reiterated: Buy
Price Target: $37 → $40
Current: $3.50
Upside: n/a
Jun 17, 2025
Reiterated: Buy
Price Target: $7
Current: $3.61
Upside: n/a
Feb 20, 2025
Reiterated: Buy
Price Target: $19 → $22
Current: $19.99
Upside: n/a
Jan 15, 2025
Reiterated: Buy
Price Target: $298
Current: $155.94
Upside: n/a
Aug 19, 2024
Reiterated: Buy
Price Target: $7 → $4
Current: $61.01
Upside: n/a
Mar 16, 2023
Rated: Buy
Price Target: $200 → $100
Current: $0.0001
Upside: n/a
Mar 8, 2023
Reiterated: Buy
Price Target: $5 → $4
Current: -
Upside: n/a
Mar 2, 2023
Rated: Hold
Price Target: $4
Current: $20.14
Upside: n/a
Mar 1, 2023
Reiterated: Buy
Price Target: $35 → $30
Current: $5.25
Upside: n/a
Mar 1, 2023
Reiterated: Buy
Price Target: $83 → $78
Current: $29.82
Upside: n/a
Feb 27, 2023
Rated: Hold
Price Target: $14
Current: $19.91
Upside: n/a
Feb 24, 2023
Reiterated: Hold
Price Target: $11.29 → $14.11
Current: $11.56
Upside: n/a
Feb 22, 2023
Rated: Buy
Price Target: $40 → $32
Current: $11.88
Upside: n/a
Jan 9, 2023
Rated: Buy
Price Target: $3
Current: $39.65
Upside: n/a
Nov 10, 2022
Reiterated: Buy
Price Target: $60 → $35
Current: $0.000001
Upside: n/a
Aug 11, 2022
Reiterated: Buy
Price Target: $27 → $25
Current: $6.14
Upside: n/a
Aug 2, 2021
Reiterated: Buy
Price Target: $180
Current: $0.9498
Upside: n/a
May 14, 2021
Rated: Buy
Price Target: $13 → $12
Current: $14.33
Upside: n/a
May 11, 2020
Reiterated: Hold
Price Target: $21
Current: $28.49
Upside: n/a
Sep 5, 2019
Reiterated: Buy
Price Target: $9 → $3
Current: $0.000001
Upside: n/a
Sep 14, 2017
Reiterated: Buy
Price Target: $80
Current: $61.86
Upside: n/a
Apr 27, 2017
Reiterated: Buy
Price Target: $138
Current: $105.59
Upside: n/a
Mar 21, 2016
Initiated Coverage: Hold
Price Target: $9.5 → $14
Current: $4.39
Upside: n/a
Oct 9, 2013
Reiterated: Hold
Price Target: $6.8
Current: $11.61
Upside: n/a